Gene · 1308
Papers3,031
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,031
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antibodies to Laminin β4 in Pemphigoid Diseases: Clinical-Laboratory Experience of a Single Central European Reference Centre. | Antibodies (Basel) | 2025 | 40843678 | PubTator, text mining | PubMed |
| Junctional Epidermolysis Bullosa Caused by a Hemiallelic Nonsense Mutation in LAMA3 Revealed by 18q11.2 Microdeletion. | Int J Mol Sci | 2025 | 40806473 | PubTator, text mining | PubMed |
| Serum levels of interleukin-17, -18, -22, and -25 in patients with bullous pemphigoid before and after treatment. | Front Med (Lausanne) | 2025 | 40800128 | PubTator, text mining | PubMed |
| TGF-β1-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and metastasis. | Cell Death Dis | 2025 | 40770187 | PubTator, text mining | PubMed |
| Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series. | J Dtsch Dermatol Ges | 2025 | 40765425 | PubTator, text mining | PubMed |
| Multi-omics and Mendelian randomization study explores potential therapeutic targets for meningiomas. | Discov Oncol | 2025 | 40751857 | PubTator, text mining | PubMed |
| Deciphering the molecular clock: exploring molecular mechanisms and genetic influences on skin ageing. | Biogerontology | 2025 | 40751759 | PubTator, text mining | PubMed |
| Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. | Sci Adv | 2025 | 40749047 | PubTator, text mining | PubMed |
| Immunotherapy-related cystitis induced by nivolumab: A case report and review of the literature. | Urol Case Rep | 2025 | 40741426 | PubTator, text mining | PubMed |
| Genetic Screening of a Nonsyndromic Amelogenesis Imperfecta Patient Cohort Using a Custom smMIP Reagent for Selective Enrichment of Target Loci. | Hum Mutat | 2025 | 40741335 | PubTator, text mining | PubMed |
| Immunophenotypic and Transcriptomic Analysis of Peripheral Blood Mononuclear Cells in Bullous Pemphigoid. | Ann Dermatol | 2025 | 40736520 | PubTator, text mining | PubMed |
| Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases. | J Neurooncol | 2025 | 40731085 | PubTator, text mining | PubMed |
| Lichen Planus Pemphigoides: A Clinical, Histopathological, and Immunological Report of 12 Indian Patients. | Indian Dermatol Online J | 2025 | 40709868 | PubTator, text mining | PubMed |
| Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid. | Front Immunol | 2025 | 40661962 | PubTator, text mining | PubMed |
| Localized genital blisters in an elderly male. | JAAD Case Rep | 2025 | 40642160 | PubTator, text mining | PubMed |
| Home-based collaborative management of bullous pemphigoid with delayed seropositive conversion of anti-BP180-NC16a antibody. | J Gen Fam Med | 2025 | 40642127 | PubTator, text mining | PubMed |
| Aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoid. | Front Immunol | 2025 | 40491922 | PubTator, text mining | PubMed |
| Innate immune cell barrier-related genes inform precision prognosis in pancreatic cancer. | Front Immunol | 2025 | 40486509 | PubTator, text mining | PubMed |
| Evaluation of tumor targets selected from public genomic databases for imaging of pancreatic ductal adenocarcinoma. | Sci Rep | 2025 | 40379788 | PubTator, text mining | PubMed |
| Rituximab for the Management of an Australian Cohort of Treatment Refractory Mucous Membrane Pemphigoid. | Australas J Dermatol | 2025 | 40377009 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1308/papers?page=8